Hemolytic uremic syndrome in solid-organ transplant recipients

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Transplant International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00336815PMID 8748414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient

  1994cited by this paper
• Haemolytic uraemic syndrome in a renal transplant recipient during OKT3 therapy.

  1994cited by this paper
• Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy.

  1994cited by this paper
• Prognostic factors of hemolytic uremic syndrome in renal allografts.

  1993cited by this paper
• FK506-associated thrombotic thrombocytopenic purpura.

  1993cited by this paper
• Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.

  1993cited by this paper
• Haemolytic uraemic syndrome during FK506 therapy.

  1992cited by this paper
• Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura

  1992cited by this paper
• Early recurrence of hemolytic uremic syndrome in a renal transplant recipient during prophylactic OKT3 therapy.

  1992cited by this paper
• Successful renal transplantation after cyclosporine-associated hemolytic-uremic syndrome following bilateral lung transplantation.

  1992cited by this paper
• Haemolytic uraemic syndrome during FK506 therapy.

  1992cited by this paper
• De novo hemolytic uremia syndrome: a rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine.

  1992cited by this paper
• Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A.

  1991cited by this paper
• Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.

  1991cited by this paper
• Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients.

  1991cited by this paper
• Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies.

  1991influential reference
• Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

  1991cited by this paper
• Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.

  1991influential reference
• Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases.

  1990cited by this paper
• Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.

  1990cited by this paper
• FK-506 and haemolytic uraemic syndrome.

  1990cited by this paper
• Hemolytic uremic syndrome following bone marrow transplantation: a case report and review of the literature.

  1989cited by this paper
• Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.

  1989cited by this paper
• Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation

  1989cited by this paper
• RECURRENT HEMOLYTIC UREMIC SYNDROME IN A RENAL TRANSPLANT RECIPIENT AND REVIEW OF THE LEIDEN EXPERIENCE

  1988cited by this paper
• Recurrent Hemolytic Uremic Syndrome in a Renal Transplant Recipient

  1988cited by this paper
• Apparent recurrence of hemolytic uremic syndrome in azathioprine-treated allograft recipients.

  1988cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-1987. A 50-year-old woman with a central nervous system disorder and renal failure two months after a renal transplant.

  1987cited by this paper
• HUS and TTP: variable expression of a single entity.

  1987cited by this paper
• HUS and TTP: Variable expression of a single entity

  1987cited by this paper
• Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation--successful treatment with plasma exchange.

  1987cited by this paper
• De novo occurrence of hemolytic-uremic syndrome in a cyclosporine-treated renal allograft patient.

  1987cited by this paper
• Cyclosporine inhibits prostacyclin production by cultured human endothelial cells.

  1987cited by this paper
• Hemolytic uremic syndrome in renal allografted patients treated with cyclosporin.

  1987cited by this paper
• Identification and treatment of cyclosporine-associated allograft thrombosis.

  1986cited by this paper
• Recurrence of hemolytic uremic syndrome in renal transplant recipients.

  1986cited by this paper
• Cyclosporine-associated microangiopathy in renal transplantation: a severe but potentially reversible form of early graft injury.

  1986cited by this paper
• De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine.

  1985cited by this paper
• Glomerular thrombi in renal allografts associated with cyclosporin treatment.

  1985cited by this paper
• Recurrent thrombotic microangiopathy in a renal allograft. Case report and review of the literature.

  1985cited by this paper
• Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.

  1984cited by this paper
• Microangiopathic hemolytic anemia associated with hyperacute rejection of a kidney allograft.

  1982cited by this paper
• Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation.

  1982cited by this paper
• Microangiopathic hemolytic anemia associated with hyperacute rejection of a kidney allograft.

  1982cited by this paper
• Selective thrombocytopenia due to localised microangiopathy of renal allografts.

  1973cited by this paper
• Late renal trnsplant failure due to the hemolytic-uremic syndrome.

  1971cited by this paper
• Renal homotransplant rejection associated with microangiopathic haemolytic anaemia.

  1970cited by this paper
• Erythrocyte deformation and hemolytic anemia coincident with the microvascular disease of rejecting renal homotransplants.

  1968cited by this paper

• Comprehensive Analysis of Thrombotic Microangiopathy Following Renal Transplantation

  2024cites this paper
• Thrombotic microangiopathy following heart transplant in pediatric Danon disease

  2020cites this paper
• Medication-Associated Glomerular Disease

  2019cites this paper
• Background and Presentation of Thrombotic Thrombocytopenic Purpura

  2018cites this paper
• Medical Management of the Lung Transplant Recipient: Extrapulmonary Issues

  2018cites this paper
• Thrombotic thrombocytopenic purpura

  2017cites this paper
• Postoperative Critical Care of Lung Transplant Patients

  2017cites this paper
• Thrombotic Thrombocytopenic Purpura Associated with Cyclocyporin Use in a Liver Transplant Patient

  2016cites this paper
• Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation.

  2016cites this paper
• Renal complications following lung and heart-lung transplantation

  2013cites this paper
• Tacrolimus‐induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients

  2013cites this paper
• The prevalence and risk factors of thrombocytopenia after living-related renal transplantation in Chinese adult recipients.

  2013cites this paper
• Thrombotic Thrombocytopenic Purpura and Related Thrombotic Microangiopathies

  2013cites this paper
• Thrombotic Microangiopathy After Living‐Donor Liver Transplantation

  2012cites this paper
• TACROLIMUS IN TRANSPLANTATION OF THE KIDNEY. COMMUNICATION 1

  2012cites this paper
• Thrombotic Thrombocytopenic Purpura, Hemolytic–Uremic Syndrome, and HELLP

  2011cites this paper
• Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

  2011cites this paper
• Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation

  2010cites this paper
• De novo Thrombotic Microangiopathy in Renal Allograft Biopsies—Role of Antibody‐Mediated Rejection

  2010cites this paper
• Review Article: Anemia post—lung transplantation: mechanisms and approach to diagnosis

  2010cites this paper
• Pegylated interferon‐α‐based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study

  2009cites this paper
• Managing complications following lung transplantation

  2009cites this paper
• Decreased ADAMTS13 levels in patients after living donor liver transplantation.

  2009cites this paper
• The thrombotic microangiopathies

  2008cites this paper
• Haemolytic Uraemic Syndrome after Living-donor Liver Transplantation: Is Small-for-size Graft a Potential Risk Factor?

  2008cites this paper
• Transplantation‐mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors

  2008cites this paper
• Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.

  2007cites this paper
• Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation

  2007cites this paper
• Journey in reverse: TTP from bedside to blood bank to bench

  2007cites this paper
• Reduced von Willebrand Factor-Cleaving Protease Levels in Secondary Thrombotic Microangiopathies and Other Diseases

  2007cites this paper
• Immune thrombocytopenic purpura following liver transplantation: A case series and review of the literature

  2006cites this paper
• Hemolytic uremic syndrome after pediatric liver transplantation.

  2006cites this paper
• Critical Care Perspective on Immunotherapy in Lung Transplantation

  2006cites this paper
• Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.

  2006cites this paper
• Thrombotic Microangiopathy With Acquired Deficiency in ADAMTS 13 Activity in Lung Transplant Recipients

  2006cites this paper
• Thrombotic Microangiopathy in Living-Donor Liver Transplantation

  2005cites this paper
• Thrombotic microangiopathy in transplantation and malignancy.

  2005cites this paper
• Thrombotic Microangiopathy in Transplantation and Malignancy

  2005cites this paper
• Drug-Induced Thrombotic Microangiopathy

  2005cites this paper
• Critical Care Aspects of Lung Transplantation

  2004cites this paper
• Post‐liver‐transplant anemia: Etiology and management

  2004cites this paper
• von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.

  2004cites this paper
• Medical complications of lung transplantation

  2004cites this paper
• Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients

  2004cites this paper
• Thrombotic thrombocytopenic purpura: survival by "giving a dam".

  2004cites this paper
• Transplantation: integration, patient selection, use of dialysis in transplant patients

  2004cites this paper
• Complicaciones médicas del trasplante de pulmón

  2004cites this paper
• Von Willebrand factor‐cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: A case report

  2003cites this paper
• Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.

  2003cites this paper
• Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma.

  2003cites this paper
• Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation.

  2003cites this paper
• Outcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal Transplantation

  2003cites this paper
• Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin.

  2003cites this paper
• Survival of renal allograft following de novo hemolytic uremic syndrome after kidney transplantation.

  2003cites this paper
• Hyperacute onset of haemolytic-uraemic syndrome associated with hyperacute rejection in the recipient of an ABO-incompatible kidney.

  2003cites this paper
• Critical Care Aspects of Lung Transplant Patients

  2002cites this paper
• Prospective analysis of thrombotic microangiopathy after renal transplantation: comparison between cyclosporine and tacrolimus immunosuppression.

  2002cites this paper
• Advances in pediatric liver transplantation: continuous monitoring of portal venous and hepatic artery flow with an implantable doppler probe.

  2002cites this paper
• Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor‐free immunosuppression regimen

  2002cites this paper
• De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination1

  2002cites this paper
• Thrombotic thrombocytopenic purpura: the systemic clumping "plague".

  2002cites this paper
• TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology.

  2002cites this paper
• Thrombotic microangiopathies.

  2002cites this paper
• Thrombotic microangiopathies in bone marrow and organ transplant patients

  2002cites this paper
• Trasplante renal pedißtrico de donante vivo relacionado.

  2001cites this paper
• Prospective analysis and successful treatment of thrombotic microangiopathy in renal allografts under tacrolimus immunosuppression.

  2001cites this paper
• Cyclosporine-triggered hemolytic-uremic syndrome in kidney graft recipients: a series of 12 cases.

  2001cites this paper
• Cyclosporine‐associated post‐partum haemolytic uraemic syndrome in a renal transplant patient: lack of response to plasmapheresis but remission after intravenous immunoglobulin G

  2001influential citation
• De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination.

  2001cites this paper
• Hemolytic Uremic Syndrome Associated with Influenza A Virus Infection in an Adult Renal Allograft Recipient: Case Report and Review of the Literature

  2000cites this paper
• Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation.

  2000cites this paper
• Hemolytic and Uremic Syndrome after Heart Transplantation

  2000cites this paper
• Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?

  2000cites this paper
• Comparison of Proteolytic Enzymes and Glutathione S-Transferase Levels in Non-Heart-Beating Donors' (NHBD) Kidney Perfusates

  2000cites this paper
• Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome.

  2000cites this paper
• Tacrolimus‐induced hemolytic uremic syndrome and end‐stage renal failure after liver transplantation

  2000cites this paper
• Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus

  2000cites this paper
• Hemolytic‐uremic syndrome in association with both cyclosporine and tacrolimus

  2000cites this paper
• THE CLINICAL IMPACT OF NEPHROTOXICITY IN LIVER TRANSPLANTATION

  2000cites this paper
• Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin.

  2000cites this paper
• Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  2000cites this paper
• Tacrolimus toxicity in rhesus monkey: model for clinical side effects.

  1999cites this paper
• Hemolytic uremic syndrome in small-bowel transplant recipients: the first two case reports

  1999cites this paper
• Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.

  1999cites this paper
• Immunosuppressive-associated leukoencephalopathy in organ transplant recipients.

  1999cites this paper
• Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement.

  1999cites this paper
• Hemolytic uremic syndrome in small‐bowel transplant recipients: the first two case reports

  1999cites this paper
• Conversion of renal transplant recipients from cyclosporin (Neoral) to tacrolimus (Prograf) for haemolytic uraemic syndrome

  1998cites this paper
• Tacrolimus in kidney transplantation. A clinical review.

  1998cites this paper
• Tacrolimus in Kidney Transplantation

  1998cites this paper
• Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.

  1998cites this paper
• Chronic renal failure following liver transplantation: a retrospective analysis.

  1998cites this paper
• Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?

  1998cites this paper
• Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?

  1998cites this paper
• Post renal transplant thrombotic microangiopathy: A single centre experience

  1998cites this paper
• Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.

  1997cites this paper
• [Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome in adults. Apropos of 27 cases].

  1997cites this paper
• Nonpulmonary medical complications in the intermediate and long-term survivor.

  1997cites this paper
• Acute renal failure in infants, children and adults.

  1997cites this paper
• Haemolytic uraemic syndrome associated with OKT3

  1996influential citation